Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK.
Pouwels KB, Pritchard E, Matthews PC, Stoesser N, Eyre DW, Vihta KD, House T, Hay J, Bell JI, Newton JN, Farrar J, Crook D, Cook D, Rourke E, Studley R, Peto TEA, Diamond I, Walker AS. · 2021
Read Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. by Pouwels KB, Pritchard E, Matthews PC, Stoesser N, Eyre DW, Vihta KD, House T, Hay J, Bell JI, Newton JN, Farrar J, Crook D, Cook D, Rourke E, Studley R, Peto TEA, Diamond I, Walker AS. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8674129.txt.
Description
Pouwels and co-authors measure vaccine protection against new SARS-CoV-2 infections as the delta variant spread in the United Kingdom. The study used a large survey of randomly chosen households. It tracked new positive tests by variant and vaccine type. Both the Pfizer and Oxford vaccines were assessed.
Protection against illness or high viral load fell with delta. The drop was 10 to 13 percent for the Pfizer vaccine. It was 16 percent for the Oxford vaccine. Two doses still matched or beat protection from past infection. The vaccines also aged in distinct ways over time. People with past infection plus vaccine had the strongest cover, and younger adults fared better.
Catalog record
| CREATOR | Pouwels KB, Pritchard E, Matthews PC, Stoesser N, Eyre DW, Vihta KD, House T, Hay J, Bell JI, Newton JN, Farrar J, Crook D, Cook D, Rourke E, Studley R, Peto TEA, Diamond I, Walker AS. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 73 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |